AUCTORES
Globalize your Research
Chat with us
Review Article | DOI: https://doi.org/10.31579/2641-0419/014
1 Department of Cardiology, Clínica Las Condes, Santiago, Chile.
2 School of Medicine Universidad del Desarrollo, Santiago, Chile
*Corresponding Author: Sonia Kunstmann F, Department of Cardiology, Clínica Las Condes, Santiago, Chile.
Citation: Sonia Kunstmann F, Fernanda Gaínza K, and Thomas Akel O. Estimating cardiovascular risk in the 21st century: role of serological markers and imaging as new tools for risk stratification. Clinical Cardiology and Cardiovascular Interventions, 2(1);Doi: 10.31579/2641-0419/014
Copyright: © 2019 Fernanda Gaínza K, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 26 March 2019 | Accepted: 08 April 2019 | Published: 12 April 2019
Keywords: cardiovascular risk; risk assessment; serological markers; cardiovascular imaging; cardiovascular disease; cardiovascular risk stratification; atherosclerosis
Cardiovascular diseases continue to be the primary cause of death worldwide, thus making their high burden a call for adequate prevention strategies. Estimating individual risk of suffering cardiac or cerebral vascular events allows the implementation of disease-modifying measures.Risk stratification charts based on traditional risk factors (sex, age, smoking, hypercholesterolemia, diabetes mellitus and hypertension) are the most recommended methods, given their easy use, high applicability and predictive value. Nevertheless, intermediate risk patients undergoing further stratification may require additional tools, such as serological markers and imaging. This review focuses on the utility and applicability of various tools designed for cardiovascular risk assessment.
Cardiovascular diseases (CVDs) continue to be the primary cause of death worldwide. Even though the general mortality rates have decreased, they are on the rise in underdeveloped and developing countries [1]. The consequent high disease burden calls for adequate prevention strategies, especially considering the early onset of atherosclerosis of coronary and cerebral arteries during childhood and that its late manifestations only permit symptomatic or palliative management, rather than a curative approach [2]. Estimating individual cardiovascular risk (CVR) allows for disease-modifying measures to be taken in order to prevent its unfavorable consequences.
Most CVR estimation tools take traditional risk factors (RF) into account (sex, age, smoking, hypercholesterolemia, diabetes mellitus and hypertension), since they have been linked to 90% of all acute myocardial infarctions [3]. However, the evaluation of said RF not always accurately predicts the risk of cardiovascular (CV) events to occur in the future. This need for optimizing prediction has led to the design of various tools aimed at determining the 5- or 10-year risk of suffering a CV event. To many clinicians, the role and utility of such tools is not free of controversy [4].
Ideally, in order to command early interventions and preventive strategies, screening should identify individuals who are at risk but are not yet known for having complications of coronary and brain atherosclerotic disease.
Due to high inter-population variability, the local incidence and prevalence of cardiovascular risk factors and events should be determined for each population.
In order to estimate CVR, many algorithm-based stratification charts and computational programs have been created as a result of several observational studies of asymptomatic individuals at risk around the world. Among others, the most popular tools are Framingham’s 2008 and the American Heart Association’s 2013 charts, as well as the Systematic Coronary Risk Estimation (SCORE) elaborated by the Task Force of European Society of Cardiology and other societies [5, 6]. These charts, recommended by most international primary care guidelines, result in overall or absolute CVR based on traditional risk factors [6, 7]. To aid in decision making, they have been adapted in many different countries according to local epidemiology, but they can also under- or overestimate individual risk, since the precise capability to distinguish between people who will or will not present a CV event is lacking.
In Chile, Kunstmann and collaborators [8] were able to obtain local epidemiological data by close follow-up of approximately 12,000 people for nearly 10 years, comprising 37,470 person years of observation; a representative sample of the national situation. Furthermore, they applied both Framingham’s original chart, a locally adapted version of it and the European algorithm to their study population. They observed significant differences regarding high and low risk estimations. After 5 years of observation, both Framingham’s chart and the European SCORE overestimated overall risk in contrast to the Chilean adjusted version, but had a better performance when it came to differentiating between those who would or would not suffer a CV event.
Individuals with known cardiovascular disease (coronary heart disease, peripheral arterial disease, cerebrovascular disease) or diabetes mellitus, must be immediately labeled as high risk and therefore require no further investigation before defining treatment.
Role Of Serological Markers In The Estimation Of Cardiovascular Risk
Many new strategies have been developed in attempt to further optimize risk stratification, such as the presence of plasmatic biomarkers. Many quantifiable molecules involved in multiple pathways of the pathophysiology concerning cardiovascular diseases have been submitted to evaluation, but only few have proven to add more value than the already existing estimation methods.
Erythrocyte sedimentation rate and C-reactive protein (CRP) are commonly measured to detect inflammation [9]. Since endothelial disease involves an inflammatory process, these markers could play a theoretically useful role. However, their limited specificity for evaluating vascular and cardiac injury has prevented their use to become universally accepted. CRP measurement is not recommended in asymptomatic patients of either low or high risk, but it is in those of intermediate risk. This mediator is linked to various metabolic and inflammatory pathways, including some associated to the formation of unstable atherosclerotic plaques [9]. The American Heart Association (AHA), along with the American College of Cardiology (ACC) consider CRP to be a valid marker for atherosclerotic disease that should be measured only in selected patients [10].
Conversely, elevated serum fibrinogen has demonstrated a high predictive value in acute myocardial and cerebral vascular injuries [11]. Markers for ischemia, such as troponins, have shown high sensitivity regarding myocardial infarction. Similarly, D-dimer (a metabolite of fibrine) is known for its use in ruling out venous thromboembolic disease.
Homocysteine, related to thrombus generation, is considered a second line CVR marker when elevated, but its reduction is not associated with a consequent decrease in risk [1].
Phospholipase A2-related lipoprotein (Lp(a)) is a precise marker for plaque rupture and atherothrombotic events. Its measurement could prove useful in secondary prevention in patients who are at high risk of CV event recurrences, but its high cost prevents its use in first line evaluation [1]. AHA/ACC 2019 guidelines suggest that it could be considered when there is family history of premature atherosclerotic disease, in which high levels should prompt a higher risk stratification [10].
Furthermore, other serological markers have shown risk-enhancing associations, such as cystatin-C and higher rates of renal failure [4].
Role Of Imaging In The Estimation Of Cardiovascular Risk
Imaging has proven to improve CVR assessment and is therefore recommended in several guidelines, such as those by the AHA/ACC 2019 and the 2016 European Task Force, among others [2, 10].
1.Cardiac computed tomography
It is a non-invasive test that evaluates cardiac anatomy. When assessing CVR it can be employed in two ways: one being computed tomography (CT) angiography, and second, Coronary Artery Calcification Score (CACS).
This imaging technique allows for visualization of the coronary arteries, comprising wall, arterial lumen and atherosclerotic plaque characteristics. This type of study may be recommended in symptomatic patients with low or intermediate pre-test risk of coronary disease [12].
On the other hand, it has not been proven to be superior to routinely implemented functional stress testing in asymptomatic patients. It is for this reason that it plays no present role in determining CVR in such patients [12].
If CT angiography were to be used in conjunction with myocardial scintigraphy and serological markers, the combined high-yield performance could be an important tool for assessing risk in terms of anatomy, physiology and functionality. However, such code of action still requires further investigation in order to be recommended accordingly.
Coronary Artery Calcification Score - CACS:
Coronary artery calcification points towards underlying atherosclerosis and has been directly associated to increasing CVR. The CACS quantifies the amount of coronary calcium to improve detection of subclinical coronary involvement and to assess CVR even further [13].
Although this can and should be considered a strong complement for initial CVR estimation, it is not recommended for follow-up evaluations due to the irreversible nature of these injuries (fibrous and calcified plaques will not be removed by statins). Its use in routine screening is not recommended. A significant limitation to this test is that only about 20% of atherosclerotic plaques are calcified and therefore a large number of them remain undetected.
Both European and American guidelines include this method for risk stratification in patients with low and especially intermediate risk [12, 14]. Early detection of subclinical disease through this method improves myocardial infarction and death prediction and can therefore be relevant in guiding therapy. For example, a recent recommendation states that in intermediate risk patients, a positive result should prompt statin therapy initiation [10].
2. Magnetic resonance imaging (MRI)
This technique contributes to both anatomical and functional cardiac assessment, especially in myocardiopathies, aortic disease and in terms of myocardial perfusion stress testing [4]. Its use in risk estimation is still limited, although new data has shown promising evidence for its utility in molecular imaging.
3.Carotid ultrasound imaging
Ultrasound of carotid arteries can reveal stenosis, thus making evident an atherosclerotic process that could otherwise remain undiagnosed. In spite of this, evidence has failed to support its use in universal screening. Conversely, it can be beneficial in intermediate risk patients without known CVD, in whom diagnosis of subclinical findings would prompt timely treatment initiation [1].
Further attempts to clarify its utility in risk stratification have found this technique to contribute to the determination of overall atherosclerotic plaques and burden (e.g. total volume of plaques in both carotid and femoral arteries), rather than the independent finding of carotid disease, and shows higher correlation with CVR [15].
4.Myocardial scintigraphy
It is a non-invasive diagnostic tool that combines the infusion of a tracer with nuclear imaging, therefore permitting evaluation of myocardial perfusion while resting as well as during cardiac stress. It is generally deemed useful when testing for coronary disease in intermediate and high-risk patients [1].
Symptomatic patients of intermediate CV risk.
Visualization of the coronary arteries, comprising wall, arterial lumen and atherosclerotic plaque characteristics.
An invasive procedure in which peripheral arterial access is obtained in order to infuse contrast medium into the coronary arteries and thus show their precise distribution, lumen and stenosis if present. It is performed in patients that are already at high risk, making it a fundamental tool in defining the need for revascularization (secondary prevention) [16].
Proper CVD prevention heavily relies on timely identification of individuals who are at significant risk of suffering cardiac or cerebral vascular injuries within the next 5 to 10 years [13]. Analyses of traditional risk factors combined with serological markers and imaging pose a considerable challenge. The large offer of tools and currently available evidence remain difficult to translate into actual clinical benefit and cardiovascular risk estimation.
Table 1 shows the pros and cons of each one of these new tools.
A recent study by Lemos and collaborators [17] evaluated multiple variables in risk estimation. Five clinical parameters were chosen (left ventricular hypertrophy shown on electrocardiogram, coronary artery calcification score (CACS), B natriuretic peptide (BNP), high sensitivity cardiac troponin and CRP). They studied two population-based cohorts of people without CVD, provided by the Multi-Ethnic Study of Atherosclerosis (MESA; n=6,621) and the Dallas Heart Study (DHS; n=2,202). These groups were followed for 10 years. Cardiovascular events (acute myocardial injury, cerebral strokes, coronary and peripheral revascularization, heart failure, atrial fibrillation and death related to any of these causes) where registered, resulting in 1,026 and 179 events in the MESA and DHS groups, respectively. Of the five parameters, all but CRP proved to be associated with overall CVD. CACS was the best predictor of coronary disease in both cohorts. All parameters were related to heart failure development, especially BNP, serum troponins and left ventricular hypertrophy. Thus, this multimodal approach improved overall CVR estimation in individuals with unknown history of CVD in both groups, but single parameters affected certain cardiovascular events to differing extents. This implies that at least some tools provide beneficial information regarding specific cardiovascular complications. A multimodal strategy would hereby increase heterogenicity of risk stratification (e.g. distinguishing high risk of suffering myocardial ischemic injuries from that of the appearance of heart failure).
A recent expert analysis led by Oren and collaborators [4] and published by the ACC, reviews the above cited study as well as the newest diagnostic tools. These authors conclude that attempting integration of all known parameters in order to predict any cardiovascular event unfortunately results in multiple false positives, thus overestimating actual risk. They also emphasize on global yet individual-oriented approach, considering each patient as a whole rather than many independent and isolated testing results. Furthermore, they question the efforts to develop new technologies to optimize risk stratification, arguing that resources should be aimed at perfecting the already existent and promising methods, such as the CACS.
Charts for CV risk estimation
Patients at risk of a CV event (without known CVD or diabetes mellitus diagnose).
Easy applicability,
widely studied.
Charts should be designed based on local prevalence of diseases. If not, risk may be under/overestimated.
Coronary artery calcification score
Asymptomatic patients of intermediate CV risk.
Early detection of subclinical disease. Good clinical correlation with CV risk.
Not useful for follow-up evaluation (only useful for initial diagnose).
Only considers calcified plaques.
Magnetic resonance imaging
Main utility in myocardiopathies. Functional and structural myocardial evaluation.
Limited contribution for CV risk assessment
Carotid ultrasound imaging
Detection of atherosclerotic disease in intermediate-risk patients.
Table 1. Summary of pros and cons of new tools developed for CVR assessment.
Symptomatic patients of intermediate CV risk.
Phospholipase A2-related lipoprotein
Patients with premature atherosclerotic disease.
Precise marker for plaque rupture and atherothrombotic events.
Patient is exposed to radiation.
Limited contribution for CV risk assessment.
Myocardial scintigraphy
Symptomatic patients of intermediate to high CV risk.
Myocardial perfusion evaluation.
High CV risk patients.
Defines management, determining need for revascularization.
Useful in advanced disease of high-risk patients.
Limited contribution in early detection or primary prevention.
Given their overall high applicability and practical use, risk stratification charts continue to be the most recommended estimation method. However, intermediate risk patients may require additional testing.
Cardiovascular risk estimation should be approached integrally, establishing overall risk and using more sophisticated diagnostic tools as long as they are ordered and analyzed within an individual’s context and with clear impact on treatment decisions.
Adding novel diagnostic methods to optimize risk estimation could increase the financial burden and hinder clinical practice, as well as reducing access to other necessary healthcare measures. Medical criterion thus calls for patient-centered rather than disease- and/or technology-driven attention.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
